Udnyttelse af CHW'er til at forbedre COVID-19-testning og afbødning blandt CJI'er, der får adgang til en korrektionsfokuseret CBO
Udnyttelse af sundhedsarbejdere i lokalsamfundet til at forbedre COVID-19-testning og afbødning blandt individer, der er involveret i strafferet, og som får adgang til en korrektionsfokuseret lokalsamfundsbaseret organisation
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Lindsey Riback, MPH
- Telefonnummer: 201-372-4089
- E-mail: lindsey.riback@einsteinmed.org
Undersøgelse Kontakt Backup
- Navn: Matthew Akiyama, MD MSc
- Telefonnummer: 718-920-7175
- E-mail: makiyama@montefiore.org
Studiesteder
-
-
New York
-
Long Island City, New York, Forenede Stater, 11101
- Fortune Society
-
The Bronx, New York, Forenede Stater, 10467
- Montefiore Medical Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Beskrivelse
Inklusionskriterier:
- 1) Fortune-kunder
- >18 år gammel
- taler flydende engelsk eller spansk
- indbyggere i NYC
- løsladt fra fængsel eller fængsel inden for 90 dage
Ekskluderingskriterier:
- Manglende evne til at give informeret samtykke
- manglende evne til at gennemføre studiebesøg over 12 måneder
- Planlægger ikke at bo i NYC-området det næste år.
- dødelig sygdom
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Screening
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: onsite Point-of-care (o-POC)
CHW'er vil kontakte deltagerne for at planlægge O-PoC-besøg.
Ved O-PoC-besøg vil CHW'er sørge for: 1. COVID-19-uddannelse; 2. PoC Cepheid XpertXpressSARS-CoV-2PCR-tests; 3. Behovsvurderinger og lettere adgang til masker og hygiejneartikler; 4. Navigation til vaccinationssteder (hvis de er tilgængelige) og enkeltværelsesboliger på Fortunes støttende boligsteder og partnerskabscentre eller alternative strategier, der vil maksimere evnen til social distance for dem, der tester PCR-positive; 5. Støttende rådgivning.
På grund af SCT's vægt på social indflydelse, ekstern og intern social forstærkning, foreslår vi, at vores O-PoC-intervention leveret af CHW'er på stedet på Fortune-lokationer over en 12-måneders periode vil føre til øget optagelse af modvirkningsadfærd.
|
Vejledt af social kognitiv teori vil O-PoC ansætte CHW'er med gennemlevet erfaring fra fængsling til at levere: 1) COVID-19 uddannelse; 2) SARS-CoV-2-test med Cepheid XpertXpress PCR-test på Fortune-faciliteter; 3) Behovsvurderinger og lettet adgang til masker og hygiejneartikler; 4) Navigation til vaccinationssteder (hvis de er tilgængelige) og enkeltværelsesboliger på Fortunes støttende boligsteder og partnerskabscentre, eller alternative strategier, der vil maksimere evnen til social afstand for dem, der tester PCR-positive; 5) Støttende rådgivning.
|
|
Ingen indgriben: Standard of Care (SOC)
Den nuværende standard for pleje (SoC) for SARS-CoV-2-testning for Fortune-klienter er henvisning til offsite community-teststeder og uformel, ustruktureret uddannelse.
I SoC-armen vil Fortune-medarbejdere give kunderne en liste over offsite SARS-CoV-2-teststeder, som er offentliggjort online og tilgængelige for alle beboere i NYC.
Dem uden forsikring er ikke omfattet af en kopi.
Deltagere i SoC vil fortsat modtage Fortunes pakke af tjenester, efterhånden som de leveres (fjernadgang og/eller personligt) på tidspunktet for studiedeltagelse.
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Testing Uptake
Tidsramme: Up to 12 months
|
Testing uptake will be defined as the number and percentage of participants who had tests performed and will be determined using program logs and healthcare record extraction.
To measure testing uptake, a dichotomous outcome of having at least one complete SARS-CoV-2 test over the 12-month study period, defined as having a test performed with results received by participants within two weeks of the test being conducted, was used.
|
Up to 12 months
|
|
Number of Participants Who Completed SARS-CoV-2 Tests
Tidsramme: Up to 12 months
|
The number/percentage of participants who completed at least one SARS-CoV-2 test for the whole 12-month study period (up to 5 tests available) is summarized by study arm.
|
Up to 12 months
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Masking Adherence
Tidsramme: 12 months post-enrollment
|
Masking adherence behavior was measured using a composite weighted variable estimating how frequently participants engaged in activities with potential COVID-19 exposure and how often they wore a mask during those activities in the previous two weeks.
Initial response options were 1=Always, 2=Most of the time, 3=Sometimes, 4=Rarely or 5=Never.
Responses were combined and standardized to a scale of 1 to 100 with higher scores indicating greater masking adherence.
Results are summarized by study arm using descriptive statistics.
|
12 months post-enrollment
|
|
Social Distancing Behavior
Tidsramme: 12 months post-enrollment
|
Social distancing measured the participants' social distancing behavior by their responses to the following question: "Overall, on a scale of 1-100, how often did you stay greater than 6 feet away from others when you were not masked in the past 2 weeks?
Higher scores were indicative of more frequent social distancing.
Results are summarized by study arm using descriptive statistics.
|
12 months post-enrollment
|
|
Hand Washing Adherence
Tidsramme: 12 months post-enrollment
|
Participants' hand washing behavior was measured by the following question: Overall, on a scale of 1-100, how often did you wash hands after shaking hands with or touching surfaces that were touched by someone else in the past two weeks?
Higher scores were indicative of more frequent hand washing behavior.
Results are summarized by study arm using descriptive statistics.
|
12 months post-enrollment
|
|
Mitigation Measures
Tidsramme: 12 months post-enrollment
|
The number/percentage of participants who reported mitigation behaviors in at least one biweekly smartphone survey is summarized by study arm.
|
12 months post-enrollment
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Matthew Akiyama, MD MSc, ALBERT EINSTEIN COLLEGE OF MEDICINE Montefiore Medical Center
Publikationer og nyttige links
Generelle publikationer
- Saloner B, Parish K, Ward JA, DiLaura G, Dolovich S. COVID-19 Cases and Deaths in Federal and State Prisons. JAMA. 2020 Aug 11;324(6):602-603. doi: 10.1001/jama.2020.12528.
- Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004 Apr;31(2):143-64. doi: 10.1177/1090198104263660.
- Greenhalgh T, Schmid MB, Czypionka T, Bassler D, Gruer L. Face masks for the public during the covid-19 crisis. BMJ. 2020 Apr 9;369:m1435. doi: 10.1136/bmj.m1435. No abstract available.
- Lyu W, Wehby GL. Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US. Health Aff (Millwood). 2020 Aug;39(8):1419-1425. doi: 10.1377/hlthaff.2020.00818. Epub 2020 Jun 16.
- Wang EA, Hong CS, Samuels L, Shavit S, Sanders R, Kushel M. Transitions clinic: creating a community-based model of health care for recently released California prisoners. Public Health Rep. 2010 Mar-Apr;125(2):171-7. doi: 10.1177/003335491012500205.
- Wang EA, White MC, Jamison R, Goldenson J, Estes M, Tulsky JP. Discharge planning and continuity of health care: findings from the San Francisco County Jail. Am J Public Health. 2008 Dec;98(12):2182-4. doi: 10.2105/AJPH.2007.119669. Epub 2008 Apr 1.
- Xiao J, Shiu EYC, Gao H, Wong JY, Fong MW, Ryu S, Cowling BJ. Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-Personal Protective and Environmental Measures. Emerg Infect Dis. 2020 May;26(5):967-975. doi: 10.3201/eid2605.190994. Epub 2020 May 17.
- Akiyama MJ, Spaulding AC, Rich JD. Flattening the Curve for Incarcerated Populations - Covid-19 in Jails and Prisons. N Engl J Med. 2020 May 28;382(22):2075-2077. doi: 10.1056/NEJMp2005687. Epub 2020 Apr 2. No abstract available.
- Kinner SA, Young JT, Snow K, Southalan L, Lopez-Acuna D, Ferreira-Borges C, O'Moore E. Prisons and custodial settings are part of a comprehensive response to COVID-19. Lancet Public Health. 2020 Apr;5(4):e188-e189. doi: 10.1016/S2468-2667(20)30058-X. Epub 2020 Mar 17. No abstract available.
- Lim YW, Andersen R, Leake B, Cunningham W, Gelberg L. How accessible is medical care for homeless women? Med Care. 2002 Jun;40(6):510-20. doi: 10.1097/00005650-200206000-00008.
- Reinhart E, Chen DL. Incarceration And Its Disseminations: COVID-19 Pandemic Lessons From Chicago's Cook County Jail. Health Aff (Millwood). 2020 Aug;39(8):1412-1418. doi: 10.1377/hlthaff.2020.00652. Epub 2020 Jun 4.
- USICH. Connecting People Returning from Incarceration with Housing and Homelessness Assistance. United States Interagency Council on Homelessness;2016.
- Levanon Seligson A, Parvez FM, Lim S, Singh T, Mavinkurve M, Harris TG, Kerker BD. Public Health and Vulnerable Populations: Morbidity and Mortality Among People Ever Incarcerated in New York City Jails, 2001 to 2005. J Correct Health Care. 2017 Oct;23(4):421-436. doi: 10.1177/1078345817727527. Epub 2017 Oct 5.
- Lim S, Seligson AL, Parvez FM, Luther CW, Mavinkurve MP, Binswanger IA, Kerker BD. Risks of drug-related death, suicide, and homicide during the immediate post-release period among people released from New York City jails, 2001-2005. Am J Epidemiol. 2012 Mar 15;175(6):519-26. doi: 10.1093/aje/kwr327. Epub 2012 Feb 13.
- Gu T, Mack JA, Salvatore M, Prabhu Sankar S, Valley TS, Singh K, Nallamothu BK, Kheterpal S, Lisabeth L, Fritsche LG, Mukherjee B. Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System. JAMA Netw Open. 2020 Oct 1;3(10):e2025197. doi: 10.1001/jamanetworkopen.2020.25197.
- Hawkins RB, Charles EJ, Mehaffey JH. Socio-economic status and COVID-19-related cases and fatalities. Public Health. 2020 Dec;189:129-134. doi: 10.1016/j.puhe.2020.09.016. Epub 2020 Oct 17.
- Puglisi L, Calderon JP, Wang EA. What Does Health Justice Look Like for People Returning from Incarceration? AMA J Ethics. 2017 Sep 1;19(9):903-910. doi: 10.1001/journalofethics.2017.19.9.ecas4-1709.
- Walsh-Felz D, Westergaard R, Waclawik G, Pandhi N. "Service with open arms": enhancing community healthcare experiences for individuals with a history of incarceration. Health Justice. 2019 Dec 19;7(1):20. doi: 10.1186/s40352-019-0101-1.
- Valera P, Boyas JF, Bernal C, Chiongbian VB, Chang Y, Shelton RC. A Validation of the Group-Based Medical Mistrust Scale in Formerly Incarcerated Black and Latino Men. Am J Mens Health. 2018 Jul;12(4):844-850. doi: 10.1177/1557988316645152. Epub 2016 May 4.
- Kutnick AH, Leonard NR, Gwadz MV. "Like I Have No Choice": A Qualitative Exploration of HIV Diagnosis and Medical Care Experiences While Incarcerated and Their Effects. Behav Med. 2019 Apr-Jun;45(2):153-165. doi: 10.1080/08964289.2019.1591338.
- Cutler DM, Summers LH. The COVID-19 Pandemic and the $16 Trillion Virus. JAMA. 2020 Oct 20;324(15):1495-1496. doi: 10.1001/jama.2020.19759. No abstract available.
- Franco-Paredes C, Jankousky K, Schultz J, Bernfeld J, Cullen K, Quan NG, Kon S, Hotez P, Henao-Martinez AF, Krsak M. COVID-19 in jails and prisons: A neglected infection in a marginalized population. PLoS Negl Trop Dis. 2020 Jun 22;14(6):e0008409. doi: 10.1371/journal.pntd.0008409. eCollection 2020 Jun. No abstract available.
- Schneider EC. Failing the Test - The Tragic Data Gap Undermining the U.S. Pandemic Response. N Engl J Med. 2020 Jul 23;383(4):299-302. doi: 10.1056/NEJMp2014836. Epub 2020 May 15. No abstract available.
- Ali S, Asaria M, Stranges S. COVID-19 and inequality: are we all in this together? Can J Public Health. 2020 Jun;111(3):415-416. doi: 10.17269/s41997-020-00351-0. Epub 2020 Jun 23. No abstract available.
- Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020 Mar;25(10):2000180. doi: 10.2807/1560-7917.ES.2020.25.10.2000180.
- Solomon L, Montague BT, Beckwith CG, Baillargeon J, Costa M, Dumont D, Kuo I, Kurth A, Rich JD. Survey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment. Health Aff (Millwood). 2014 Mar;33(3):434-42. doi: 10.1377/hlthaff.2013.1115.
- Ott IM, Strine MS, Watkins AE, Boot M, Kalinich CC, Harden CA. Simply saliva: stability of SARS-CoV-2 detection negates the need for expensive collection devices. medRxiv 2020080320165233;
- Bannan CL, Lynch PA, Conroy EP, O'Dea S, Surah S, Betts-Symonds G, Lyons FE. Point-of-care testing for HIV in an Irish prison setting: results from three major Irish prisons. Int J STD AIDS. 2016 Oct;27(11):950-4. doi: 10.1177/0956462415601340. Epub 2015 Sep 16.
- Beckwith CG, Atunah-Jay S, Cohen J, Macalino G, Poshkus M, Rich JD, Flanigan TP, Lally MA. Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS. 2007 Jan;21(1):41-7. doi: 10.1089/apc.2006.006.
- Beckwith CG, Kurth AE, Bazerman LB, Patry EJ, Cates A, Tran L, Noska A, Kuo I. A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections. J Public Health (Oxf). 2016 Mar;38(1):130-7. doi: 10.1093/pubmed/fdv023. Epub 2015 Mar 2.
- Wolters F, van de Bovenkamp J, van den Bosch B, van den Brink S, Broeders M, Chung NH, Favie B, Goderski G, Kuijpers J, Overdevest I, Rahamat-Langedoen J, Wijsman L, Melchers WJ, Meijer A. Multi-center evaluation of cepheid xpert(R) xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic. J Clin Virol. 2020 Jul;128:104426. doi: 10.1016/j.jcv.2020.104426. Epub 2020 May 11.
- Frank JW, Wang EA, Nunez-Smith M, Lee H, Comfort M. Discrimination based on criminal record and healthcare utilization among men recently released from prison: a descriptive study. Health Justice. 2014 Mar 25;2:6. doi: 10.1186/2194-7899-2-6.
- Fox AD, Anderson MR, Bartlett G, Valverde J, Starrels JL, Cunningham CO. Health outcomes and retention in care following release from prison for patients of an urban post-incarceration transitions clinic. J Health Care Poor Underserved. 2014 Aug;25(3):1139-52. doi: 10.1353/hpu.2014.0139.
- Wang EA, Hong CS, Shavit S, Sanders R, Kessell E, Kushel MB. Engaging individuals recently released from prison into primary care: a randomized trial. Am J Public Health. 2012 Sep;102(9):e22-9. doi: 10.2105/AJPH.2012.300894. Epub 2012 Jul 19.
- Collica-Cox K. Female Offenders, HIV Peer Programs, and Attachment: The Importance of Prison-Based Civilian Staff in Creating Opportunities to Cultivate Prosocial Behaviors. Int J Offender Ther Comp Criminol. 2018 Feb;62(2):524-550. doi: 10.1177/0306624X16650680. Epub 2016 May 23.
- Collica-Cox K. Counting down: HIV prison-based peer education programs and their connection to reduced disciplinary infractions. Int J Offender Ther Comp Criminol. 2014 Aug;58(8):931-52. doi: 10.1177/0306624X13490660. Epub 2013 Jun 11.
- Cunningham WE, Weiss RE, Nakazono T, Malek MA, Shoptaw SJ, Ettner SL, Harawa NT. Effectiveness of a Peer Navigation Intervention to Sustain Viral Suppression Among HIV-Positive Men and Transgender Women Released From Jail: The LINK LA Randomized Clinical Trial. JAMA Intern Med. 2018 Apr 1;178(4):542-553. doi: 10.1001/jamainternmed.2018.0150.
- Ballard M, Bancroft E, Nesbit J, Johnson A, Holeman I, Foth J, Rogers D, Yang J, Nardella J, Olsen H, Raghavan M, Panjabi R, Alban R, Malaba S, Christiansen M, Rapp S, Schechter J, Aylward P, Rogers A, Sebisaho J, Ako C, Choudhury N, Westgate C, Mbeya J, Schwarz R, Bonds MH, Adamjee R, Bishop J, Yembrick A, Flood D, McLaughlin M, Palazuelos D. Prioritising the role of community health workers in the COVID-19 response. BMJ Glob Health. 2020 Jun;5(6):e002550. doi: 10.1136/bmjgh-2020-002550.
- Bhaumik S, Moola S, Tyagi J, Nambiar D, Kakoti M. Community health workers for pandemic response: a rapid evidence synthesis. BMJ Glob Health. 2020 Jun;5(6):e002769. doi: 10.1136/bmjgh-2020-002769.
- Peretz PJ, Islam N, Matiz LA. Community Health Workers and Covid-19 - Addressing Social Determinants of Health in Times of Crisis and Beyond. N Engl J Med. 2020 Nov 5;383(19):e108. doi: 10.1056/NEJMp2022641. Epub 2020 Sep 23. No abstract available.
- Counihan H, Harvey SA, Sekeseke-Chinyama M, Hamainza B, Banda R, Malambo T, Masaninga F, Bell D. Community health workers use malaria rapid diagnostic tests (RDTs) safely and accurately: results of a longitudinal study in Zambia. Am J Trop Med Hyg. 2012 Jul;87(1):57-63. doi: 10.4269/ajtmh.2012.11-0800.
- Boyce MR, Menya D, Turner EL, Laktabai J, Prudhomme-O'Meara W. Evaluation of malaria rapid diagnostic test (RDT) use by community health workers: a longitudinal study in western Kenya. Malar J. 2018 May 18;17(1):206. doi: 10.1186/s12936-018-2358-6.
- Jefferson T, Del Mar C, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, van Driel ML, Nair S, Foxlee R, Rivetti A. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006207. doi: 10.1002/14651858.CD006207.pub3.
- Matrajt L, Leung T. Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease. Emerg Infect Dis. 2020 Aug;26(8):1740-1748. doi: 10.3201/eid2608.201093. Epub 2020 Apr 28.
- MacIntyre CR, Cauchemez S, Dwyer DE, Seale H, Cheung P, Browne G, Fasher M, Wood J, Gao Z, Booy R, Ferguson N. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis. 2009 Feb;15(2):233-41. doi: 10.3201/eid1502.081167.
- Alsan M, Stantcheva S, Yang D, Cutler D. Disparities in Coronavirus 2019 Reported Incidence, Knowledge, and Behavior Among US Adults. JAMA Netw Open. 2020 Jun 1;3(6):e2012403. doi: 10.1001/jamanetworkopen.2020.12403.
- Frimpong JA, Shiu-Yee K, Tross S, D'Aunno T, Perlman DC, Strauss SM, Schackman BR, Feaster DJ, Metsch LR. Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results: A Randomized Trial. Med Care. 2020 May;58(5):445-452. doi: 10.1097/MLR.0000000000001311.
- Frimpong JA, D'Aunno T, Perlman DC, Strauss SM, Mallow A, Hernandez D, Schackman BR, Feaster DJ, Metsch LR. On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial. Trials. 2016 Mar 3;17(1):117. doi: 10.1186/s13063-016-1225-4.
- Rosenberg ES, Dufort EM, Blog DS, Hall EW, Hoefer D, Backenson BP, Muse AT, Kirkwood JN, St George K, Holtgrave DR, Hutton BJ, Zucker HA; New York State Coronavirus 2019 Response Team. COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020. Clin Infect Dis. 2020 Nov 5;71(8):1953-1959. doi: 10.1093/cid/ciaa549.
- Jing QL, Liu MJ, Zhang ZB, Fang LQ, Yuan J, Zhang AR, Dean NE, Luo L, Ma MM, Longini I, Kenah E, Lu Y, Ma Y, Jalali N, Yang ZC, Yang Y. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. Lancet Infect Dis. 2020 Oct;20(10):1141-1150. doi: 10.1016/S1473-3099(20)30471-0. Epub 2020 Jun 17.
- Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, Emperador D, Takwoingi Y, Cunningham J, Beese S, Dretzke J, Ferrante di Ruffano L, Harris IM, Price MJ, Taylor-Phillips S, Hooft L, Leeflang MM, Spijker R, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020 Aug 26;8(8):CD013705. doi: 10.1002/14651858.CD013705.
- Pasomsub E, Watcharananan SP, Boonyawat K, Janchompoo P, Wongtabtim G, Suksuwan W, Sungkanuparph S, Phuphuakrat A. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Clin Microbiol Infect. 2021 Feb;27(2):285.e1-285.e4. doi: 10.1016/j.cmi.2020.05.001. Epub 2020 May 15.
- Akiyama MJ, Kaba-Diakite F, Dimaulaluan M, Riback LR, Antigua JR, Holmes CS, Ackerman MF, Castillo A, Linder M, Day RF, Travers A, Cunningham CO, Deng Y, Zhang C, Fox AD. Mitigation of COVID-19 through onsite testing and education among formerly incarcerated individuals (the MOSAIC study): an open-label, single-centre, randomised controlled trial. Lancet Public Health. 2026 Jul;11(7):e457-e467. doi: 10.1016/S2468-2667(26)00093-9.
Hjælpsomme links
- Johns Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)
- Federal Bureau of Prisons - Inmate Ethnicity Statistics
- The Marshall Project. A State-by-State Look at Coronavirus in Prisons
- American Civil Liberties Union. COVID-19 Model Finds Nearly 100,000 More Deaths Than Current Estimates, Due to Failures to Reduce Jails
- Prison Policy Initiative - Jails versus Prison
- Covid-19: Testing Inequality in New York City
- No COVID-19 tests available for prisoners at center of New York outbreak, court documents show
- Audit of Brooklyn federal jail claims lack of COVID-19 tests may have masked size of outbreak New York Daily News.
- Nelson J. House Appropriations Committee Approves '21 Funding for DOJ Programs
- Cepheid. Sars-cov-2-test-development-information
- Evidence-Based, Cost-Effective Interventions To Suppress The COVID-19 Pandemic: A Systematic Review
- Facemasks and similar barriers to prevent respiratory illness such as COVID-19
- The Institute for Health Metrics and Evaluation - Daily deaths during the pandemic
- The National Reentry Resource Center. Reentry Services Directory
- Estimating QALY losses associated with deaths in hospital (COVID-19)
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 2021-12976
- 5R01MD016744 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .